Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 03:27 ET | Source: GENENTA SCIENCE SPA

Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini

MILAN, March 24, 2026 (GLOBE NEWSWIRE) -- Genenta Science S.p.A. (Nasdaq: GNTA) transforming to Saentra Forge1, a strategic industrial consolidator focused on biotech, defense, aerospace, and...
March 24, 2026 02:00 ET | Source: Regeneron Pharmaceuticals, Inc.

Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)

Approval in moderate-to-severe patients was based on pivotal trial results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo ...
March 24, 2026 02:00 ET | Source: Pharming Group N.V.

Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older

First approved treatment in Japan for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS)Approval is based on positive Phase III data from multinational and Japanese studies in patients...
March 23, 2026 23:31 ET | Source: Yimutian Inc.

Yimutian Inc. to Acquire Ningbo Xunxi Technology for RMB 50 Million, Entering the Enterprise Digital Commerce Market

Xunxi brings RMB 340 million in audited 2025 revenue, 200+ institutional clients, and a 2 million-member digital commerce platform.
March 23, 2026 22:00 ET | Source: LOBO EV TECHNOLOGIES LTD.

LOBO Announces Pricing of $2 Million Public Offering

WUXI, China, March 23, 2026 (GLOBE NEWSWIRE) -- LOBO TECHNOLOGIES LTD. (NASDAQ: LOBO) (“LOBO” or the “Company”), an innovative electric vehicles manufacturer and seller, today announced that it has...
March 23, 2026 21:38 ET | Source: Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering

Sol-Gel Technologies Ltd. Announces Pricing of Oversubscribed Underwritten Offering
March 23, 2026 17:30 ET | Source: Outlook Therapeutics, Inc.

Outlook Therapeutics Announces Proposed Public Offering

ISELIN, N.J., March 23, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of...
March 23, 2026 17:30 ET | Source: Rush Enterprises, Inc.

Rush Enterprises announces appointment of Jody Pollard as Chief Operating Officer

Rush Enterprises announces appointment of COO
March 23, 2026 17:00 ET | Source: Weatherford International, LLC

Weatherford Announces First-Quarter 2026 Conference Call

HOUSTON, March 23, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) will host a conference call on Wednesday, April 22, 2026 to discuss the...
March 23, 2026 16:32 ET | Source: Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026

Monday, March 30: Phase 1 data on TNX-4800 (long-acting anti-Borrelia OspA human monoclonal antibody) for the seasonal prevention of Lyme disease Wednesday, April 1: Animal and in vitro studies on...